These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8717073)

  • 1. Endothelin is a key modulator of progressive renal injury: experimental data and novel therapeutic strategies.
    Bruzzi I; Benigni A
    Clin Exp Pharmacol Physiol; 1996 Apr; 23(4):349-53. PubMed ID: 8717073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of endothelin in the progression of the renal disease in an experimental model of chronic kidney failure].
    Orisio S; Zoja C; Remuzzi G
    Ann Ital Med Int; 1993; 8(4):213-7. PubMed ID: 8161475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin: a mediator of renal disease progression.
    Bruzzi I; Remuzzi G; Benigni A
    J Nephrol; 1997; 10(4):179-83. PubMed ID: 9377723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein content.
    Bertani T; Zoja C; Abbate M; Rossini M; Remuzzi G
    Lab Invest; 1989 Feb; 60(2):196-204. PubMed ID: 2915514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.
    Ortmann J; Amann K; Brandes RP; Kretzler M; Münter K; Parekh N; Traupe T; Lange M; Lattmann T; Barton M
    Hypertension; 2004 Dec; 44(6):974-81. PubMed ID: 15545511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I; Krzymański M
    Przegl Lek; 1996; 53(5):443-53. PubMed ID: 8754411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.
    Brenner BM; Meyer TW; Hostetter TH
    N Engl J Med; 1982 Sep; 307(11):652-9. PubMed ID: 7050706
    [No Abstract]   [Full Text] [Related]  

  • 8. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis.
    Velosa JA; Holley KE; Torres VE; Offord KP
    Mayo Clin Proc; 1983 Sep; 58(9):568-77. PubMed ID: 6887974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of proteinuric renal disease and the emerging role of endothelin.
    Barton M
    Nat Clin Pract Nephrol; 2008 Sep; 4(9):490-501. PubMed ID: 18648345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
    Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
    Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression.
    Orisio S; Benigni A; Bruzzi I; Corna D; Perico N; Zoja C; Benatti L; Remuzzi G
    Kidney Int; 1993 Feb; 43(2):354-8. PubMed ID: 8441230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endothelin in the development of glomerulosclerosis.
    Remuzzi G
    Kidney Blood Press Res; 1996; 19(3-4):182-3. PubMed ID: 8887257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gremlin - a putative pathogenic player in progressive renal disease.
    Dolan V; Murphy M; Alarcon P; Brady HR; Hensey C
    Expert Opin Ther Targets; 2003 Aug; 7(4):523-6. PubMed ID: 12885271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin antagonists and renal protection.
    Benigni A; Perico N; Remuzzi G
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S75-78. PubMed ID: 10976787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelin and endothelin receptor antagonists in renal disease.
    Neuhofer W; Pittrow D
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():78-88. PubMed ID: 16919017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-associated nephropathy: experimental models.
    Avila-Casado C; Fortoul TI; Chugh SS
    Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent focal glomerulosclerosis in renal transplants.
    Axelsen RA; Seymour AE; Mathew TH; Fisher G; Canny A; Pascoe V
    Clin Nephrol; 1984 Feb; 21(2):110-2, 113-4. PubMed ID: 6373077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of progression of renal disease: growth factors and related mechanisms.
    Benigni A; Remuzzi G
    J Hypertens Suppl; 1998 Sep; 16(4):S9-12. PubMed ID: 9817186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.